References
- Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670–3
- Galdbart JO, Morvan A, Desplaces N, El Solh N. Phenotypic and genotypic variation among Staphylococcus epidermidis strains infecting joint protheses. J Clin Microbiol 1999; 37: 1306–12
- van Eldere J, Peetermans WE, Struelens M, Deplano A, Bobbaers H. Polyclonal staphylococcal endocarditis caused by genetic variability. Clin Infect Dis 2000; 31: 24–30
- Proctor RA. Editoral response: coagulase-negative staphylococcal infections: a diagnostic and therapeutic challenge. Clin Infect Dis 2000; 31: 31–3
- Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318–22
- Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganism. Clin Microbiol Rev 2002; 15: 167–93
- Von Eiff C, Bettin D, Proctor R, Rolauffs B, Lindner N, Winkelmann W, et al. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 1997; 25: 1250–1
- van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Staphylococcus aureus biofilm formation on different gentamicin-loaded polymethylmethacrylate bone cements. Biomaterials 2001; 22: 1607–11
- Thomes B, Murray P, Bouchier-Hayes D. Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg 2002; 84: 758–60
- Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ. Residual gentamicin release from antibiotic-loaded polymethylmethacrylate beads after 5 y of implantation. Biomaterials 2003; 24: 1829–31
- Hanssen AD. Prophylactic use of antibiotic bone cement. J Arthroplasty 2004; 19(Suppl. 1)73–7
- Bert F, Clarissou J, Durand F, Delefosse D, Chauvet C, Lefebvre P, et al. Prevalence, molecular epidemiology and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients. J Clin Microbiol 2003; 4: 5147–52
- Ariza J, Pujol M, Cabo J, Pena C, Fernandez N, Linares J, et al. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 1999; 353: 1587–8
- Desplaces N, Mamoudy P, Ducroquet F, Larrouturou PH, Kitzis MD. Vancomycine en perfusion continue et infections ostéo-articulaires à staphylocoques multirésistants. Med Mal Infect 1997; 27: 969–74
- Goldstein F, Kitzis MD. Vancomycin-resistant Staphylococcus aureus: no apocalypse now. Clin Microbiol Infect 2003; 9: 761–5
- Kitzis MD, Goldstein F. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections. Clin Microbiol Infect 2006; 12: 92–5
- Lundstrom TS, Sobel JD. Antibiotics for Gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid. Infect Dis Clin North Am 2000; 14: 463–74